Pharmaceutical Developer Champions Strict Science Over Commercial Cannabis in Medicare Dispute

New York, Monday, 25 May 2026.
After a judge dismissed their Medicare lawsuit without reviewing the science, MMJ International rejected anti-marijuana labels, prioritizing FDA-regulated chemistry and patient safety over commercial cannabis markets.